Leptin receptor signaling regulates protein synthesis pathways and neuronal differentiation in pluripotent stem cells by Gupta, Manoj K. et al.
Stem Cell Reports
ArticleLeptin Receptor Signaling Regulates Protein Synthesis Pathways and Neuronal
Differentiation in Pluripotent Stem Cells
Manoj K. Gupta,1,2 Heidrun Vethe,1,3 Samir Softic,4,5 Tata Nageswara Rao,1,10 Vilas Wagh,6 Jun Shirakawa,1,2
Harald Barsnes,3,7 Marc Vaudel,3,7 Tomozumi Takatani,1,2 Sevim Kahraman,1,2 Masaji Sakaguchi,5
Rachael Martinez,1 Jiang Hu,1 Yngvild Bjørlykke,3,8 Helge Raeder,3,8 and Rohit N. Kulkarni1,2,9,*
1Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA
2Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02215, USA
3KG Jebsen Center for Diabetes Research, Department of Clinical Medicine, University of Bergen, Bergen 5009, Norway
4Department of Gastroenterology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02215, USA
5Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA
6Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02114, USA
7Proteomics Unit, Department of Biomedicine, University of Bergen, Norway
8Department of Pediatrics, Haukeland University Hospital, N-5021 Bergen, Norway
9Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02215, USA
10University Clinic of Hematology, Department of Biomedical Research, Inselspital Bern and University of Bern, Bern, Switzerland
*Correspondence: rohit.kulkarni@joslin.harvard.edu
https://doi.org/10.1016/j.stemcr.2020.10.001SUMMARYThe role of leptin receptor (OB-R) signaling in linkingpluripotencywith growth and development and the consequences of dysfunctional
leptin signaling on progression of metabolic disease is poorly understood. Using a global unbiased proteomics approach we report that
embryonic fibroblasts (MEFs) carrying the db/db mutation exhibit metabolic abnormalities, while their reprogrammed induced plurip-
otent stem cells (iPSCs) show altered expression of proteins involved in embryonic development. An upregulation in expression of eu-
karyotic translation initiation factor 4e (Eif4e) and Stat3 binding to the Eif4e promoter was supported by enhanced protein synthesis in
mutant iPSCs. Directed differentiation of db/db iPSCs toward the neuronal lineage showed defects. Gene editing to correct the pointmu-
tation in db/db iPSCs using CRISPR-Cas9, restored expression of neuronal markers and protein synthesis while reversing the metabolic
defects. These data imply a direct role for OB-R in regulating metabolism in embryonic fibroblasts and key developmental pathways in
iPSCs.INTRODUCTION
Mutations in different exons in the leptin receptor (OB-R)
gene have been reported to cause obesity, pituitary
dysfunction, and metabolic abnormalities in humans
(Clement et al., 1998; Saeed et al., 2014). The db/dbmouse,
which harbors a mutation in the OB-R gene (G to T transi-
tion in the intron region between exon 18 and exon 19),
manifests features that are strikingly similar to those seen
in humans carrying the mutant receptor, such as obesity,
type 2 diabetes, and tumorigenesis (Chen et al., 1996; Ko-
bayashi et al., 2000; Wang et al., 2014). Thus, the db/db
mouse continues to be widely used as a suitable model to
explore the role of OB-R in the development and progres-
sion of obesity, diabetes, and its related complications.
While a majority of circulating leptin originates from adi-
pose tissue, other tissues also contribute, such as the
placenta,ovaries, testes, skeletalmuscle, cartilage,bonecells,
and stomach (Margetic et al., 2002). Following secretion lep-
tin actsmainly via theOB-R, ofwhich several isoforms exist,
differing mainly in the length of the cytoplasmic domain
(Chenet al., 1996). In addition to expression in adult tissues,
suchas theheart,pancreaticbeta-cells, and immunecells the
OB-R has been detected in fetal and developmental tissues,Stem Cell Reports
This is an open access article under the Cincluding placenta, endometrium, and pluripotent stem
cells (El-Hefnawy et al., 2000; Hoggard et al., 2001). Further-
more, leptin, secreted by fibroblasts, has been reported to
support proliferation of human pluripotent stem cells (Ani-
simov et al., 2011) and a previous study demonstrated bind-
ing of pluripotency factors, Oct4 and Sox2, on the promoter
region of OB-R (Feldman et al., 2012). Recently, leptin
signaling has been suggested to regulate the parasympa-
thetic nervous system during early embryonic development
(Croizier et al., 2016). Thus, while studies point to a role for
leptin receptors during early development the direct func-
tional role of OB-R in modulating pluripotency and its con-
sequences on development is unknown.
In this study, we used mouse embryonic fibroblasts
(MEFs) and iPSCs derived from db/db mice as complemen-
tary model systems to explore OB-R signaling in the
regulation of pluripotency and metabolic/mitochondrial
function during embryonic development. Strikingly, db/
db MEFs exhibited an upregulated ERK pathway and meta-
bolic dysfunction, while db/db iPSCs showed reduced plu-
ripotency and differential regulation of protein synthesis
pathways. The latter defects in iPSCs were reversed upon
correction of the db/db point mutation by genome editing
using the clustered regularly interspaced short palindromicj Vol. 15 j 1067–1079 j November 10, 2020 j ª 2020 The Authors. 1067
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
repeats (CRISPR-Cas9) approach. These findings were sup-
ported by RNA sequencing (RNA-seq) analyses on iPSCs.
Furthermore, we report a role for OB-R signaling during
neuronal development. Together these data indicate the
significance of the OB-R in regulating genes/proteins rele-
vant for pluripotency, protein synthesis pathways, and
neuronal development with potential implications for can-
cer and metabolic diseases.RESULTS
Functional Characterization and Global Proteomics
Reveal Metabolic Abnormalities in Embryonic
db/db MEFs
Global differential protein expression betweenCtrl and db/
db MEFs, investigated by mass spectrometry-based prote-
omics, revealed 38 strongly and 92 moderately regulated
proteins that were significantly different between groups
(detailed in the Experimental Procedures). The most differ-
entially regulated proteins between Ctrl and db/db MEFs
were those related tomitochondrial function and oxidative
phosphorylation. The differentially regulated proteins and
pathways are listed in Table S1 (Figures 1A, S1A, and S1B).
The most differentially regulated pathways included
mitochondrial dysfunction, oxidative phosphorylation,
and integrin signaling, while the moderately regulated
pathways were insulin growth factor 1 signaling, cell cycle,
BMP signaling, DNA methylation, molecular mechanisms
of cancer, adipogenesis, leptin signaling in obesity, and
protein ubiquitination. The complete list of regulated path-
ways is presented in Table S2.
To validate the key pathways we began with morpholog-
ical characterization and observed largerMEFs in the db/db
group (Figure S1C). We observed an upregulation of phos-
phorylation of MEK1/2, ERK1/2, and RAPTOR in db/db
MEFs (Figure 1B), and the abundance of CDKN2a was upre-
gulated in these MEFs (Figure S1D). Together, these data
point to differential regulation of the MEK/ERK/RAPTOR
pathway and mitochondrial dysfunction in db/db MEFs
during embryonic development and suggest a link between
OB-R and obesity and oncogenesis.db/db iPSCs Show Altered Morphology and
Pluripotency Characteristics
We confirmed the persistence of the leptin receptor muta-
tion (G to T transition) in the db/db group by sequencing
genomic DNA (Figures 1C and S2A). While no difference
in colony morphology was evident between the two
groups, a significantly larger cell size was detected in db/
db iPSCs (Figures 1D and S2B). Interestingly, western blot
analysis showed significant downregulation of Oct4 and
Nanog protein levels in db/db iPSCs (Figures 1E–1G).1068 Stem Cell Reports j Vol. 15 j 1067–1079 j November 10, 2020To explore their ability to spontaneously differentiate
in vivo into the three germ layers we injected Ctrl or db/
db iPSCs (1 3 106 cells/mouse) either subcutaneously or
intramuscularly into severe combined immunodeficient
(immunodeficient) and B6 (syngeneic) mice. As expected,
we observed teratomas in both groups and the presence
of b-III-tubulin (ectoderm in green), a-actinin (mesoderm
in green), and HNF-3-b (endoderm in red) (Figures S2C
and S2D) confirmed components of the three germ layers.
Global Proteomics Analyses of Ctrl and db/db iPSCs
Reveals Differentially Regulated Pathways Associated
with Pluripotency and Protein Synthesis
To interrogate changes in the global proteome we under-
took systematic comparisons between MEFs and iPSCs
separately in Ctrl and db/db groups as well as Ctrl iPSCs
versus db/db iPSCs. We identified 665 strongly regulated
proteins and 278 moderately regulated proteins that were
significantly different between the two cell types (Ctrl
MEFs versus Ctrl iPSCs) (Table S3). A comparison between
db/db MEFs and db/db iPSCs, revealed 789 strongly regu-
lated proteins and 271 moderately regulated proteins that
reached statistical significance (Table S4). Comparing the
proteome between Ctrl and db/db iPSCs, we identified 32
significantly and moderately regulated proteins (Table S5).
Next, to assess the specific effects of leptin signaling at
the proteome level in pluripotent stem cells, we aimed to
identify a protein signature consequent to deregulated
OB-R signaling in induced pluripotent stem cells derived
from db/db mice. The heatmap analyses revealed that
mitochondrial proteins, protein synthesis, and pluripotent
pathways were differentially regulated between Ctrl and
db/db iPSCs (Figures 1H and S3A). As expected, iPSCs
fromCtrl and db/db showed fewer differences in proteomic
changes than the differentiated MEFs from the two respec-
tive groups. Specifically, up to 150 proteins were signifi-
cantly differently expressed in the db/db MEF-specific
proteome comparedwith 75 in the db/db iPSC-specific pro-
teome, with five proteins being significantly differently ex-
pressed in both proteomes (Figure 1I).
Notably, many of the highly regulated proteins in the db/
dbMEF-specific proteomedid not persist in the iPSC-specific
proteome, suggesting a shutdown or suppression of db/db-
specific proteins and pathways after the MEF cells were re-
programmed into pluripotent cells (Figures 1I and 1J).
Upregulated Eukaryotic Translation Initiation Factor
4E Protein Synthesis Pathway and Higher Metabolic
Rates in Db/db iPSCs
Proteomic analyses revealed an upregulation of the eukary-
otic translation initiation factor 4e (EIF4E) protein synthe-
sis pathway among the canonical networks in the iPSCs of
db/db mice. The complete list of differentially regulated
Ctrl db/db
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Figure 1. Altered Metabolic Regulation in db/db MEFs and Reduced Pluripotency and Upregulated Protein Synthesis Pathway in
db/db iPSCs
(A–G) (A) Heatmap representation of differentially expressed proteins between Ctrl and db/db MEFs. A selection of gene ontology terms is
given for each protein cluster. Red indicates upregulated while green indicates downregulated proteins in db/db MEFs. (B) Western blots
analysis showing upregulated MEK1/2, ERK1/2, and RAPTOR pathways in db/db MEFs. b-Actin was used as a loading control. (C) Genomic
DNA sequencing showing G to T transition of base in db/db iPSCs. (D) Cell diameter of Ctrl and db/db iPSCs using Cello meter. (E) Western
blot analysis of OCT4 and NANOG in four different clones from Ctrl and db/db iPSCs; quantification of changes in OCT4 (F) and NANOG (G)
using ImageJ software. b-Actin was used as a loading control.
(H–J) (H) Heatmap representation of pathway analysis of differentially expressed proteins between Ctrl and db/db iPSCs. A selection of GO
terms is given for each protein cluster. Red indicates upregulated while green indicates downregulated proteins in db/db iPSCs. (I) Venn
diagram showing the numbers of proteins that were significantly differently expressed (p < 0.05) in db/db MEF-specific proteome and the
db/db iPSC-specific proteome. Five proteins were significantly changed between db/db and Ctrl, both before and after reprogramming. (J)
Pairing of protein expression values from each of the significant proteins in the db/db MEF-specific proteome with the db/db iPSC-specific
proteome.pathways is available in Table S2 (Figures S3A and S3B; Ta-
bles S2 and S5).
We next considered previous reports that tissues mani-
festing the db/db mutation exhibit altered signal trans-
ducer and activator of transcription 3 (STAT3) signaling.
Interestingly, while the effects of the db/db mutation
have been observed in the hypothalamus (Ghilardi et al.,
1996) leptin has been reported not to activate the Stat
pathway in other adult tissues (Vaisse et al., 1996). The
latter prompted us, for the first time, to examine STAT3
activation in iPSCs. In the unstimulated state, Ctrl iPSCsshowed higher phosphorylation of STAT3, which robustly
increased after stimulation with leukemia inhibitory factor
(LIF) or leptin. The mutant db/db iPSCs showed a similar
level of phosphorylation of STAT3 as compared with Ctrl
iPSCs in the unstimulated state. Although db/db iPSCs
also demonstrated phosphorylation of STAT3 after stimu-
lation with LIF, the effect was significantly blunted after
leptin stimulation indicating defective signaling (Fig-
ure S3C). Furthermore, OCT4 protein abundance was
decreased in db/db iPSCs in the starved condition similar
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Figure 2. Upregulated Protein Synthesis in db/db iPSCs
(A–E) (A) Western blot analysis showing increase in phospho-EIF4E, phopho-EIF4G, and total EIF4E in db/db iPSCs. (B and C) quantifi-
cation of the data in (A) phospho-EIF4E (B) and phospho-EIF4G (C). (D) metabolic profiling by Seahorse showing higher oxygen con-
sumption rate (OCR) in db/db iPSCs as compared with Ctrl iPSCs. (E) Flow cytometry analysis showing relative higher mitochondrial mass
(Mito-GFP) in db/db iPSCs.
(F–I) (F) Representative polysome profiling graphs showing polysome and monosome peaks in Ctrl (left panel, in black) and db/db iPSCs
(right panel, in red). (G) Quantification of polysome and monosome ratios in both groups. (H) Anti-puromycin western blot analysis
demonstrated higher protein synthesis in db/db iPSCs as compared with Ctrl iPSCs. a-Tubulin was used as a loading control. (I) Quan-
tification of newly synthesized proteins in Ctrl and db/db iPSCs using a-tubulin as a loading control. n = 3 independent experiments; data
are shown as mean ± SD by Student’s t test (*p < 0.05, **p < 0.01).EIF4E, as well as phosphorylated EIF4E, were signifi-
cantly upregulated in the basal state, in agreement with
mass spectrometry data on db/db iPSCs (Figures S3A and
S3B). Phosphorylated EIF4G was also significantly upregu-
lated in db/db iPSCs in the basal state as compared with
Ctrl iPSCs (Figures 2A–2C). These results indicate that dis-
rupted leptin receptor signaling leads to higher abundance
of proteins that regulate protein synthesis in the pluripo-
tent stage.
Next, metabolic profiling revealed higher basal oxygen
consumption rate (OCR) in db/db iPSCs, indicating
an increased metabolic rate/oxidative phosphorylation
(OXPHOS) compared with Ctrl iPSCs (Figure 2D). Electron1070 Stem Cell Reports j Vol. 15 j 1067–1079 j November 10, 2020microscopy and flow cytometry analysis revealed relatively
higher mitochondrial numbers in db/db iPSCs (Figures 2E
and S4A). There was also a significant upregulation in the
expression of Pgc-beta and G6pd genes in db/db iPSCs as
compared with Ctrl iPSCs (Figures S4B and S4C). Together,
these data suggest that the presence of the db/db mutation
is associated with higher metabolic activity in the iPSCs.
Polysome Profiling Reveals Higher Protein Synthesis
in db/db iPSCs: Role of Stat3 Binding to eIF4E
Promoter
Since proteins related to protein synthesis were upregu-





















IgG STAT3 IgG STAT3 IgG STAT3 IgG STAT3
IgG STAT3 IgG STAT3 IgG STAT3 IgG STAT3
Ctrl db/db Ctrl db/db










STAT3 DAPI merge STAT3 DAPI merge









G G A G G T A  A A






























































Figure 3. Chromatin Immunoprecipitation Analysis for Stat3-Eif4e Binding and CRISPR Correction of the db/db Mutation in iPSCs
(A–E) (A) Chromatin immunoprecipitation analysis showing higher Stat3 binding (relative enrichment) on the two promoter regions ‘‘a’’
and ‘‘b’’ of Eif4e in db/db iPSCs using four different sets of primers 1a, 1b and 2a, 2b. (B) Live-confocal microscopy reveals the predominant
nuclear localization of STAT3 in db/db iPSCs compared with cytosolic localization of STAT3 in Ctrl iPSCs. Scale bar, 20 mm. Each row
indicates a single clone from Ctrl and db/db iPSCs. (C) db/db mutation (G to T) in the intronic region between exon 18 and exon 19, and
DNA sequencing reveals the reversal of one copy to wild type in db/db iPSCs. Similar results were obtained in two additional clones. (D)
Western blot analysis showing restoration of protein abundance of OCT4 and NANOG in CRISPR-corrected (db/Corr) iPSCs. a-Tubulin was
used as a loading control. (E) Metabolic profiling showed similar basal respiration in db/db-corrected iPSCs compared with Ctrl iPSCs.
(F and G) (F) Anti-puromycin western blot analysis showing normalization of protein synthesis in CRISPR-corrected db/Corr iPSCs. b-Actin
was used as a loading control. (G) Quantification of data from experiment in (F), n = 3 independent experiments; data are shown as mean ±
SD and analyzed by Student’s t test (*p < 0.05, **p < 0.01).and observed a higher polysome/monosome ratio in db/db
iPSCs suggesting enhanced protein synthesis (Figures 2F
and 2G). These data were confirmed by an alternative
non-radioactive approach (Schmidt et al., 2009) wherein
addition of puromycin to a growing culture of Ctrl or db/
db iPSCs led to increased protein synthesis in the latter at
the end of 48 h (Figures 2H and 2I). In silico analysis re-
vealed two Stat3 binding regions on the promoter of the
Eif4e gene, whichmight be involved in cellular protein syn-
thesis (Figure S5A). Indeed, chromatin immunoprecipita-
tion (ChIP) analysis by real-time PCR, to validate binding
of Stat3 to the promoter of Eif4e, showed significantlygreater enrichment of Stat3 binding on the Eif4e promoter
region in db/db iPSCs as compared with Ctrl iPSCs. The
relative enrichment of two Stat3 binding regions (region
1: from 841 to 834; region 2: from 168 to 160) on
the promoter of Eif4e were achieved by using 2 pairs of
primers to examine each region (1a, 1b for ‘‘GGCTTCCC’’
and 2a, 2b for ‘‘TTCCCAGAA’’) in real-time PCR analysis
(Figures 3A and S5B). Moreover, live immunostaining
showed predominantly nuclear localization of STAT3 in
db/db iPSCs even in the basal state (Figure 3B). Together,
these results implicate a role for Stat3 in the regulation of
protein synthesis via Eif4e in db/db iPSCs.Stem Cell Reports j Vol. 15 j 1067–1079 j November 10, 2020 1071
CRISPR-Cas9 Correction of db/db iPSCs Normalizes
Altered Protein Synthesis and Pluripotency Pathways
To determine whether the mutation in the OB-R is directly
relevant for the phenotypes observed in the iPSCs, we de-
signed guide RNAs to target and correct the G to T point
mutation using CRISPR-Cas9 genome editing. A control
template with the wild-type sequence was used to replace
the mutation (Figure S6A). Among the 192 clones selected
for sequencing we identified two clones with one copy re-
verted to the wild-type sequence (db/+), hereafter termed
db/Corr iPSCs (Figures 3C and S6B). To examine the effect
of the db/db mutation, we performed molecular and func-
tional analysis of Ctrl and CRISPR-corrected (db/Corr)
iPSCs.Western blot analysis showed that db/Corr iPSCs ex-
hibited EIF4E and OCT4 protein expression that was
similar to Ctrl iPSCs in the basal state (Figures 3D and
S6C). Furthermore, metabolic profiling demonstrated
similar levels of OCR in the mutation db/Corr iPSCs and
Ctrl iPSCs (Figure 3E). Anti-puromycin antibody-based
Western blot analyses also revealed that protein synthesis
in CRISPR-corrected db/Corr iPSCs is not significantly
different from Ctrl iPSCs (Figures 3F and 3G).
RNA-Seq Analyses of iPSCs Authenticate the Role of
OB-R in Protein Synthesis and Pluripotency Pathways
To confirm our previous findings, we conducted RNA-seq
analyses on Ctrl, db/db, and db/Corr iPSCs. A total of
1,662 upregulated and 1,887 downregulated genes were
determined between Ctrl and db/db iPSCs with false dis-
covery rate < 0.25 and adjusted p value < 0.05. This
included 651 upregulated genes and 630 downregulated
genes between db/db versus Ctrl and db/Corr versus Ctrl
iPSCs. Gene ontology and pathway analyses between Ctrl
and db/db iPSCs showed an upregulation in the ERK and
EIF pathways and downregulation in insulin secretion,
alanine-glutamate metabolism, and tyrosine metabolic
pathways (Figures 4A and 4B). Heatmaps confirmed the
proteomics data with an upregulation of genes related to
the protein synthesismachinery (Figures 4C and 5A), while
pluripotency-associated genes were downregulated (Fig-
ures 4D and 5B) in db/db iPSCs. These alterations were
reversed in db/Corr iPSCs.
Volcano plots between db/db versus Ctrl iPSCs revealed
the top differentially regulated genes of OB-R in the plurip-
otent state (Figure 4E; Table S6). Validation studies using
real-time PCR analyses confirmed the changes in several
genes, including an upregulation of Eif4e, Eif1ax, caveo-
lae-associated protein 4 (Cavin4), and fatty acid binding
protein 3 (Fabp3), and downregulation of solute carrier
family 29, member 3 (Slc29a3), tripartite motif-containing
44 (Trim44), and transmembrane protein 132c (Tmem132c)
genes in db/db iPSCs. Again, the differential regulation was
normalized in db/Corr iPSCs (Figure 5C).1072 Stem Cell Reports j Vol. 15 j 1067–1079 j November 10, 2020Directed Differentiation of iPSCs Reveals a Role for
OB-R Signaling in Development of the Neuronal
Lineage
To investigate the role of leptin receptor signaling in tissues
originating from the ectoderm we directed the differentia-
tion toward the neuronal lineage (Gupta et al., 2018; Ying
et al., 2003). After differentiation of the iPSCs, we observed
downregulation of the neural progenitor markers Noggin
and Nestin, while Tubb3+ did not show significant changes
at the transcript level on day 15 in the db/db as compared
withCtrls (Figure5D). Immunostaining analyses confirmed
the decrease in NOGGIN+ cells (58.5%; p < 0.0001, n = 4)
and glial fibrillary acidic protein (GFAP)+ cells (45.5%;
p = 0.0019, n = 4) in db/db compared with Ctrl-derived
neuronal cells. NESTIN+ cells were decreased in the db/db
iPSC-derived neurons (5.4%, p = 0.07, n = 3) as compared
with Ctrl neurons (Figures 5E–5H). Morphological images
were taken at day 15 differentiated neuronal cells from
Ctrl, db/db, and db/Corr iPSCs (Figure 6A). Despite a rela-
tively small decrease in cell numbers we confirmed a
decrease inNESTINprotein in db/dbneuronal cells bywest-
ern blot (45%; p < 0.05, n = 4) and flow cytometry analysis
(52.1%; p < 0.0001, n = 3; decrease in mean fluorescent in-
tensity) as compared with Ctrl neurons (Figures 6B–6D).
The decrease in NOGGIN+ cells was also confirmed by
flow cytometry analysis (60.3%; p < 0.0001, n = 3) in db/
db neurons as compared with Ctrl neurons (Figure 6E).
Importantly, the changes in expressionofneuronalmarkers
were normalized in db/Corr neurons that were differenti-
ated after correction using CRISPR-Cas9. These results pro-
vide direct evidence that defects in leptin receptor signaling
prompts mouse iPSCs to reduced/delayed differentiation
toward the ectodermal lineage.DISCUSSION
db/db mice that manifest impaired leptin signaling are
widely used as a disease model (Bates et al., 2005; Ernst
et al., 2013). These homozygous mutant mice are born nor-
mally but develop diabetes and metabolic abnormalities
at 6–8 weeks of age characterized by mitochondrial
dysfunction (Holmstrom et al., 2012; Wang et al., 2014)
while the heterozygous mice are relatively normal (Kobaya-
shi et al., 2000). We report, for the first time, metabolic
dysfunction and upregulated MEK/ERK pathways in the
db/db embryonic fibroblasts that were morphologically
larger and exhibited greater glycolytic and OX/PHOS
capacities.
We used a proteomics approach and confirmed altered
expression of OCT4 and EIF4E protein synthesis pathways
in the db/db iPSCs. These observations have significant im-






































Figure 4. RNA-Seq Analyses Confirms Upregulation of Protein Synthesis Pathways and Downregulation of Pluripotency-Associated
Genes
(A–C) Red color indicates upregulated pathways (A) and blue color indicates downregulated pathways (B) in db/db iPSCs as compared with
Ctrl iPSCs. (C) Several genes related to protein synthesis pathways were upregulated in db/db iPSCs and were normalized after CRISPR-Cas9
correction of iPSCs.
(D) Pluripotency genes were downregulated in db/db iPSCs.
(E) Volcano plot showing differentially regulated genes between Ctrl and db/db iPSCs. Red color indicates genes that are upregulated and
blue color indicates downregulated genes in db/db iPSCs as compared with Ctrl iPSCs. n = 3 independent experiments; data are shown as
mean ± SD and analyzed by Student’s t test (*p < 0.05, **p < 0.01).roles in maintaining pluripotency of iPSCs (Boiani et al.,
2002; Chambers et al., 2003) and a quantitative change
in the expression of Oct4 leads to differentiation, de-differ-entiation, or self-renewal of iPSCs (Niwa et al., 2000). Inter-
estingly, RNA-seq analyses demonstrated that the expres-
sion of Nanog, Tbx3, Panct2, and Zfp42 were all decreasedStem Cell Reports j Vol. 15 j 1067–1079 j November 10, 2020 1073
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Figure 5. Neuronal Differentiation of Ctrl, db/db, and db/Corr iPSCs Points to a Role for Leptin Receptors in the Regulation of Early
Neuronal Markers
(A) Heatmap analyses showing upregulation of top differentially regulated genes in db/db iPSCs that were normalized in db/Corr iPSCs.
(B) Heatmap analyses showing downregulation of top differentially regulated genes in db/db iPSCs that were normalized in db/Corr iPSCs.
Genes in red color denote upregulation while genes in blue color represent downregulation. Pathway analyses were conducted using Limma
pathway software.
(C) Real-time PCR analyses of Eif4e, Eif1ax, Cavin4, Fabp3 (upregulated in db/db iPSCs), and Slc29a3, Trim44, Tmem132c (downregulated in
db/db iPSCs) as a comparison with Ctrl iPSCs. Expression of these genes was normalized in corrected db/Corr iPSCs. b-Actin was used as a
loading control. Gene expression in blue indicates Ctrl iPSCs, in green indicates db/db iPSCs, and in red indicates corrected db/Corr iPSCs.
(D) Real-time PCR analyses of early neuronal markers Noggin, Nestin, and Tubb3 in total RNA from day 15 neuronal cells.
(E–G) Representative images of Ctrl, db/db, and db/corr iPSC-derived neuronal cells (day 15) immunostained for markers of neuronal cells
(E) NOGGIN (in red), (F) NESTIN (in green), and (G) GFAP (in green). All nuclei were stained in blue with DAPI. Mouse brain tissue was used
as positive control. Scale bar, 100 mm.
(H) At least four independent images of each marker were quantified by manual counting. The percent of positive cells of each neuronal
marker was determined by counting approximately 1,000 nuclei/image. n = 3 independent experiments; data are shown as mean ± SD and
analyzed by Student’s t test (*p < 0.05, **p < 0.01).in db/db iPSCs, while the Oct4 transcript levels did not
change. One interpretation of the latter observation is
that OB-R is involved in post-transcriptional regulation of
OCT4 at the pluripotent stage. Nevertheless, the reduced
abundance of OCT4, NANOG, and other pluripotency
markers in the db/db iPSCs suggests a potential impact
on the differentiation process.
The translation initiation factor, eIF4e, has been reported
to play an important role in protein synthesis and cell1074 Stem Cell Reports j Vol. 15 j 1067–1079 j November 10, 2020growth (Gingras et al., 1999; Sonenberg and Gingras,
1998). Our data indicate that disruption of OB-R leads to
enhanced protein synthesis likely due persistent activation
of Stat3 binding to the promoter of Eif4e in db/db iPSCs as
shown by ChIP analysis and immuno-staining. While
these observations may appear contradictory to previous
reports of leptin stimulating protein synthesis in human
trophoblast cells (Perez-Perez et al., 2009), and leptin acting
via the OB-R to promote Stat3 phosphorylation and
200 m
















































































































Figure 6. Neuronal Differentiation of db/Corr iPSCs Shows the Ability of Gene Editing to Restore the Defects in Regulation of Early
Neuronal Markers
(A) Morphological images of cells on day 15 of directed differentiation of Ctrl, db/db, or db/+ iPSCs. Scale bar, 200 mm.
(B) Total protein was isolated from day 15 differentiated neuronal cells. NESTIN antibody was used to detect its abundance in day 15
neuronal cells from Ctrl, db/db, or db/Corr groups. a-Tubulin was used as housekeeping control as shown in representative western blot.
(C and D) (C) Quantification of NESTIN western blot using ImageJ software. (D) NESTIN mean fluorescent intensity measurement of Ctrl,
db/db, and db/Corr iPSC differentiated neuronal cells by flow cytometry.
(E) Flow cytometry analyses of NOGGIN+ cells from differentiated neuronal cells of Ctrl, db/db, and db/Corr iPSCs.
n = 3 independent experiments; data are shown as mean ± SD and analyzed by Student’s t test (*p < 0.05, **p < 0.01).
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nuclear translocation in tumor initiating stem cells (Feld-
man et al., 2012), it is possible that leptin-activated Stat3
has context-dependent effects during the pluripotent
stage. Furthermore, one cannot exclude the possibility of
MEK/ERK pathways in activating EIF4E protein synthesis,
similar to the effect of leptin on human trophoblast cell
lines, in db/db iPSCs.
The successful restoration of metabolic function, plurip-
otency genes, and protein synthesis after correction of the
db/db mutation (G to T) on one allele in db/Corr iPSCs us-
ing CRISPR-Cas 9 genome editing (Hsu et al., 2014) con-
firms a direct role for OB-R in maintenance of pluripotency
and cell differentiation processes. The RNA-seq data on
iPSCs confirms the observations after gene correction of
OB-R with normalization of expression of several genes
including Eif4e, Eif1ax to the level observed in Ctrl iPSCs.
Consistent with the report of leptin signaling being
linked to neuronal embryonic development (Croizier
et al., 2016), we observed a decrease in NOGGIN and
GFAP+ cells and reduction in NESTIN protein, on day 15
of neuronal differentiation of db/db iPSCs. These changes
were normalized in neuronal cells obtained from CRISPR-
corrected db/Corr iPSCs. Mice lacking NOGGIN have
been reported to develop defects in hypothalamic
patterning, which is important for maintaining energy ho-
meostasis during adulthood (Davis and Camper, 2007).
Thus, in this scenario, and based on our findings, it is plau-
sible that a decrease in NOGGIN+ cells in db/db mice dur-
ing development leads to impaired development of POMC
and AgRP neurons with consequences on development of
obesity, diabetes, andmetabolic syndrome as themouse at-
tains adulthood. Nestin has been reported to be important
for self-renewal of neural progenitor cells and axonal
growth of neurons (Bott et al., 2019) and its deficiency
has been linked to impaired motor coordination (Mohseni
et al., 2011). In our study, the reduction in Nestin protein
could affect the neuronal projections/axonal growth that
would in turn lead to impairment of normal neuronal
development and coordination during adulthood.
Notably, previous studies by Ramos-Lobo et al. (2019) re-
ported reduced Gfap expression in the hypothalamus of
LepR null mice during early life with long-term conse-
quences. Another study reported that modulation of
Gfap-expressing glial cells in the hypothalamus is able to
regulate feeding (Chen et al., 2016). In the context of these
reports, the reduction in GFAP+ cells in db/db neuronal
cells, as compared with Ctrl and db/Corr neurons, in our
own study, argues for a potential reduction in GFAP+ glial
cells in the hypothalamus with implications for feeding
behavior. Our studies also gain significance sincemetabolic
defects in the db/db mice, in contrast to the ob/ob model,
cannot be fully restored by treatment with exogenous
leptin (Pellymounter, 1995; Harris, 2001). Taken together,1076 Stem Cell Reports j Vol. 15 j 1067–1079 j November 10, 2020our findings indicate that normal leptin receptor expres-
sion and signaling regulates neural stem cell markers
(e.g., NOGGIN andNESTIN) andGFAP protein during early
developmental stages, which is necessary for maintenance
of normal structural and/or functional properties of neu-
rons populating the hypothalamus with implications for
development of metabolic disorders in adulthood.
In summary, we report defects in MEFs and iPSCs
derived from db/db mice with several implications. First,
the regulation of Nanog, Tbx3, and Zfp42 at the transcript
level and OCT4, and NANOG at the protein level in cells
with the db/db mutation suggests a role for leptin
signaling in regulation of ‘‘stemness.’’ Second, linking
db/db signaling to protein synthesis pathways via the
Stat3/Eif4e axis in iPSCs provides insights in understand-
ing the incidence of cancer in leptin receptor dysfunc-
tional states. Third, a decrease in the stem cell markers
NOGGIN, NESTIN, and GFAP during directed differentia-
tion of db/db iPSCs suggests a role for OB-R signaling in
the regulation of neuronal development. Thus, db/db
MEFs and iPSCs provide useful tools (depicted in the
Graphical Abstract) to explore the relevance of OB-R in
the early origins of obesity, diabetes, and metabolic abnor-
malities, and to find putative targets for harnessing thera-
peutics to prevent the development of these diseases.EXPERIMENTAL PROCEDURES
Mice and MEFs
All studies involving mice were approved by the institutional re-
view board of the Joslin Diabetes Center and were in accordance
with NIH guidelines. Embryonic day 14.5 wild-type control (Ctrl)
(N = 4) and db/db MEFs (N = 4) were derived from breeding
OB-Rdb/+ heterozygous mice (Jackson Laboratory). All fibroblasts
weremaintainedup to amaximumpassage10 inDulbeccomodi-
fied Eagle’s medium supplemented with GlutaMAX, 10% fetal
bovine serum (FBS), and 1% nonessential amino acids.
Lentiviral-Mediated Reprogramming and iPSC
Generation and Characterization
Generation of mouse iPSCs involved infection of primary MEFs
with mouse STEMCCA lentivirus vector expressing the reprog-
ramming factors Oct4, Sox2, Klf4, and cMyc. iPSC characterization
involved teratoma formation, H&E staining, and immunostain-
ing for the three lineage markers staining performed according
to previous reports (Bhatt et al., 2015; Sommer et al., 2009; Teo
et al., 2013). More information is available in the Supplemental
material.
Gene Expression Analyses Using Quantitative RT-PCR
and Western Immunoblotting
RNAwas isolated from cells using RNeasy kit (QIAGEN) and cDNA
was prepared from 1 mg of RNA using the RT-PCR kit (Life Technol-
ogies) according to themanufacturer’s instructions and diluted to a
final volume of 250 mL. In parallel experiments total cellular pro-
teins were harvested using M-PER mammalian protein extraction
reagent (Thermo Scientific) followed by western immunoblotting
of proteins. More information about antibodies is included in Sup-
plemental material.Gene Correction in db/db iPSCs Using CRISPR-Cas9
The Cas9 and sgRNA plasmid pX459 were obtained from Addgene
(plasmid no. 48139). Guide RNAs (20 bps) were chosen that lie in
the intronic region between exons 18 and 19 of the OB-R gene us-
ing the CRISPR Design Tool (http://crispr.mit.edu/). The sequence
of sgRNA cloned in vector wasCACCGGATGTTTACATTTTGATGG
(sgRNA-01), and a 200-nt DNA oligo complementing the region





TAGT, purchased as ssODNUltramer Oligo from IDT). db/db iPSCs
cells were electroporated using 500 ng of vector and 50 pmol of
ssODN template using Amaxa Nucleofector (cat. no. VAPH-1001,
Nucleofector Program A-23). Cells were plated on a 15-cm dish
and, after overnight culture, 50 ng/mL of puromycin selection
was applied for the first 2 days of culture. Colonies started appear-
ing within 5–7 days and individual colonies/clones were manually
picked and transferred to 48-well plates.
Genotyping for 100 cloneswas performed by extracting genomic
DNA (PureLink Genomic DNA Kit, Thermo Fischer Scientific) that
was subjected to PCR (using F primer TCTCTGAATCCTTGCTC
TTTGT, R primer CATGTGGTTGCTGGGATTTG) followed by
Sanger sequencing using sequencing primer CCCTCTCCTAA
GTGTGTCACTA. Data from sequencing traces were analyzed
using SeqmanPro software (Lasergene SeqMan Pro version 8.1;
DNASTAR). Clones with and without gene correction were
compared for in vitro studies (isogeneic pair). In addition the clones
were analyzed for potential off-target effects for top predicted off-
target sites (NCBI-BLAST) using the Sanger sequencing method.Flow Cytometry
iPSCs derived from Ctrl and db/db MEFs were trypsinized using
0.05% trypsin-EDTA. Single cells were stained for Mito-GFP dye
with proper isotype controls using methods described previously
(Gupta et al., 2015). For neuronal marker staining, cells were har-
vested and fixed in 4% paraformaldehyde for 15 min at room
temperature. Cells were then spun and washed with cold fluores-
cence-activated cell sorting (FACS) buffer (5% FBS in PBS). Perme-
abilization and blocking was carried out on ice for 30 min in
FACS buffer with 0.1% Triton X-100. Antibody staining was per-
formed on ice for 30 min using chicken anti-NESTIN (1:100,
NB100-1604; Novus Biologicals), rabbit anti-NOGGIN (1:50, ab-
16054, Abcam) followed by incubation with secondary antibody
(anti-chicken Alexa 488 and anti-rabbit Alexa 594; 1:1,000, Invi-
trogen) for 30 min on ice. Cells were washed and resuspended in
250 mL FACS buffer and filtered through a 30-mm filter before
analysis by LSR II (BD Biosciences, Joslin Flow Cytometry
Core). Gating was determined according to the secondary-only
controls.Metabolic Profiling
Bioenergetic profiles ofMEFs andmouse iPSCswere generated using
a Seahorse Bioflux Analyzer as reported earlier (Kleinridders et al.,
2013). The brief method is described in the Supplemental material.
Chromatin Immunoprecipitation and
Immunofluorescence
In brief, Ctrl and db/db iPSCs were fixed in 1% formaldehyde, and
quenched in glycine. Cells were washed with PBS and lysed in cold
lysis buffer with protease and phosphatase inhibitors (Sigma).
Cells were then sonicated using 25% of power, 10-s on/off pulses
for a total of 3 min. Immunoprecipitations were performed using
anti-STAT3 antibody (SantaCruz). Ctrl and db/db iPSCswere trans-
ferred onto poly-L-lysine pre-coated cover slips and incubated at
37C for 24 h. Cells on cover slips were fixed with 2% formalde-
hyde and stainedwith anti-STAT3 antibody followed by anti-rabbit
IgG Alexa 594 (Molecular Probes). Cover slips were mounted with
Fluorescent Mounting Media (DAKO) and cells were analyzed un-
der a Carl Zeiss LSM7 confocal laser scanning microscope.
Immunohistochemistry
Neuronal cells grown on glass slides were fixed in 4% paraformal-
dehyde solution (Wako) before staining with specific primary anti-
bodies as described previously.More information is available in the
Supplemental material.
Mass Spectrometry Analyses
We generated biological replicates for each of the db/db and Ctrl
mouse cell cultures, both before (i.e., from MEFs; n = 2 + 2 repli-
cates) and after reprogramming (i.e., from iPSCs; n = 4 + 4 repli-
cates) as outlined in Figure S2. Subsequently, the eight iPSC and
four MEF cell lines were multiplexed by isobaric labeling and sub-
jected to independent liquid chromatography-mass spectrometry
analysis as described in the Supplemental material.
RNA-Seq Analyses
We isolated total RNA from Ctrl (N = 4), db/db (N = 4), and db/Corr
(N = 2) iPSCs in duplicates and sent it out to DNA Link for
sequencing. RNA-seq data were analyzed in the Joslin Bioinformatic
core facility. RNA-seq raw reads were downloaded from DNA Link,
which were reverse stranded paired-end reads. There were 14,245
genes after filtering out the low expressing genes. We then normal-
ized counts byweighted trimmedmean ofM values. The normaliza-
tion factors were between 0.93 and 1.08. Detailed methods for
analyses are described in the Supplemental material.
Neuronal Differentiation
Fifty thousand Ctrl, db/db, and db/Corr iPSCs were plated on
gelatin-coated six-well plates and differentiated up to 15 days in
NDiff 227 medium (Clontech). Cells were harvested on day 15
for transcript and western blot analyses for neuronal markers.
Data and Code Availability
The accession number for the RNA-seq data reported in this paper
is GSE155704 proteomics data reported in this paper via Proteo-
meXchange with identifier is PXD020959.Stem Cell Reports j Vol. 15 j 1067–1079 j November 10, 2020 1077
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2020.10.001.
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